封面
市场调查报告书
商品编码
1392515

2024 年生物材料全球市场报告

Biomaterials Global Market Report 2024

出版日期: 按订单生产 | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来,生物材料市场规模迅速扩大。将从2023年的1,185.1亿美元成长到2024年的1,360.8亿美元,复合年增长率为14.8%。历史时期的成长是由人口高龄化的加剧、整形外科和牙科应用中生物材料的采用、环境永续性意识的提高、慢性病医学的普及以及医疗植入的使用增加所推动的。这是由于需求的增加。

心血管疾病发生率的上升正在推动生物材料市场的成长。心血管疾病是由高血压、吸烟、高胆固醇、缺乏运动和其他因素引起的。心血管疾病盛行率的增加主要是由于非传染性疾病,如糖尿病、慢性呼吸道疾病、冠状动脉疾病(CAD)和高血压引起的心臟疾病。心臟瓣膜、心肺体外迴圈系统、支架、血管移植物、完整的人造心臟和起搏器等生物材料被用作受损或患病心臟组织的癒合机制。例如,根据美国公共机构疾病管制与预防中心的数据,2023 年5 月,冠状动脉疾病(CAD) 将在2021 年导致375,476 人死亡,约每20 名20 岁以上成年人中就有1 人死于冠状动脉疾病。有CAD。大约十分之二的 CAD 死亡病例是 65 岁以下的成年人。因此,心血管疾病盛行率的增加可能会增加对生物材料市场的需求。

医疗保健支出的增加将推动生物材料市场的成长。医疗保健支出是指在一定时期内分配给医疗服务、治疗和医疗保健基础设施的财政资源总额,通常是在国家或机构层级。医疗保健支出用于生物材料的研发、产品开发、采购、招聘和监管合规。例如,根据代表欧洲医疗技术产业的比利时产业协会 MedTech Europe 的数据,到 2022 年 9 月,欧洲平均约有 11% 的国内生产总值(GDP) 分配给医疗保健。其中约 7.6% 分配给医疗技术。欧洲国家的医疗技术支出约占医疗保健总支出的 5% 至 12%。欧洲人均健康技术支出约为 346.08 美元(284 欧元)。因此,增加医疗保健支出将有助于生物材料市场的成长。

2023年生物材料市场最大的地区将是北美。生物材料市场报告涵盖的地区包括亚太地区、西欧、东欧、北美、南美、中东和非洲。

目录

第一章执行摘要

第二章 生物材料市场特点

第三章生物材料市场趋势与策略

第四章生物材料市场 - 宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章全球生物材料市场规模及成长

  • 全球市场驱动因素与抑制因素
    • 市场驱动因素
    • 市场抑制因素
  • 2018-2023 年全球市场规模实绩与成长
  • 全球市场规模预测与成长,2023-2028、2033

第六章生物材料市场区隔

  • 全球生物材料市场,按类型细分、实绩和预测,2018-2023、2023-2028F、2033F
  • 金属生物材料
  • 高分子生物材料
  • 天然生物材料
  • 陶瓷
  • 全球生物材料市场,按应用细分、实绩和预测,2018-2023、2023-2028F、2033F
  • 心血管
  • 整形外科
  • 眼科
  • 牙科
  • 整形外科
  • 创伤治疗
  • 人体组织工程
  • 神经系统/中枢神经系统
  • 全球生物材料市场,依最终用途、实绩和预测细分,2018-2023、2023-2028F、2033F
  • 医院和诊所
  • 门诊手术中心
  • 其他最终用户

第七章生物材料市场区域与国家分析

  • 全球生物材料市场,按地区、实绩和预测,2018-2023、2023-2028F、2033F
  • 全球生物材料市场,依国家、实绩及预测,2018-2023、2023-2028F、2033F

第八章亚太生物材料市场

  • 概述
  • 区域资讯、COVID-19 影响、市场资讯、背景资讯、政府配合措施、法规、监管机构、关键机构、课税、公司税务结构、投资、主要企业
  • 按类型、实绩和预测细分,2018-2023、2023-2028F、2033F
  • 按应用、实绩和预测细分,2018-2023、2023-2028F、2033F
  • 依最终用途、实绩和预测细分,2018-2023、2023-2028F、2033F

第九章 中国生物材料市场

第十章 印度生物材料市场

第十一章 日本生物材料市场

第十二章 澳洲生物材料市场

第十三章 印尼生物材料市场

第14章 韩国生物材料市场

第十五章西欧生物材料市场

  • 概述
  • 按类型、实绩和预测细分,2018-2023、2023-2028F、2033F
  • 按应用、实绩和预测细分,2018-2023、2023-2028F、2033F
  • 依最终用途、实绩和预测细分,2018-2023、2023-2028F、2033F

第十六章英国生物材料市场

第十七章 德国生物材料市场

第十八章 法国生物材料市场

第十九章 义大利生物材料市场

第20章 西班牙生物材料市场

第21章 东欧生物材料市场

  • 概述
  • 按类型、实绩和预测细分,2018-2023、2023-2028F、2033F
  • 按应用、实绩和预测细分,2018-2023、2023-2028F、2033F
  • 依最终用途、实绩和预测细分,2018-2023、2023-2028F、2033F

第22章 俄罗斯生物材料市场

第23章 北美生物材料市场

  • 概述
  • 按类型、实绩和预测细分,2018-2023、2023-2028F、2033F
  • 按应用、实绩和预测细分,2018-2023、2023-2028F、2033F
  • 依最终用途、实绩和预测细分,2018-2023、2023-2028F、2033F

第24章美国生物材料市场

第25章 加拿大生物材料市场

第26章 南美洲生物材料市场

  • 概述
  • 按类型、实绩和预测细分,2018-2023、2023-2028F、2033F
  • 按应用、实绩和预测细分,2018-2023、2023-2028F、2033F
  • 依最终用途、实绩和预测细分,2018-2023、2023-2028F、2033F

第27章巴西生物材料市场

第28章中东生物材料市场

  • 概述
  • 按类型、实绩和预测细分,2018-2023、2023-2028F、2033F
  • 按应用、实绩和预测细分,2018-2023、2023-2028F、2033F
  • 依最终用途、实绩和预测细分,2018-2023、2023-2028F、2033F

第29章 非洲生物材料市场

  • 概述
  • 按类型、实绩和预测细分,2018-2023、2023-2028F、2033F
  • 按应用、实绩和预测细分,2018-2023、2023-2028F、2033F
  • 依最终用途、实绩和预测细分,2018-2023、2023-2028F、2033F

第30章生物材料市场竞争形势及公司概况

  • 生物材料市场竞争形势
  • 生物材料市场公司概况
    • Carpenter Technology Corporation
    • Corbion NV
    • Evonik Industries AG
    • Heraeus Medical Components LLC
    • Berkeley Advanced Biomaterials Inc.

第31章全球生物材料市场的竞争基准化分析

第32章全球生物材料市场竞争仪錶板

第三十三章生物材料市场重大併购

第34章生物材料市场未来展望及潜力分析

第35章附录

简介目录
Product Code: r10203

“Biomaterials Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biomaterials market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biomaterials? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The biomaterials market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Type: Metallic Biomaterial; Polymeric Biomaterials; Natural Biomaterials; Ceramics
  • 2) By Application: Cardiovascular; Orthopedic; Ophthalmology; Dental; Plastic Surgery; Wound Healing; Tissue Engineering; Neurological/Central Nervous System
  • 3) By End Use: Hospitals And Clinics; Ambulatory Surgical Centers; Other End Users
  • Companies Mentioned: Carpenter Technology Corporation; Corbion N V; Evonik Industries AG; Heraeus Medical Components LLC; Berkeley Advanced Biomaterials Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

The biomaterials refer to manmade substances that can be utilized to support tissues or structures in the body. These are natural or synthetic materials that are used in medical applications to support, enhance, or replace damaged tissue or a biological function.

The main types of biomaterials are metallic biomaterial, polymeric biomaterials, natural biomaterials and ceramics. The metallic biomaterials are stainless steels, titanium alloys, and cobalt alloys used to provide internal support to biological tissues. The metallic biomaterials are manmade systems that are utilized in joint replacements, dental implants, orthopedic fixations, and stents to offer internal support to biological tissues. Biomaterials have a wide application in cardiovascular, orthopedic, ophthalmology, dental, plastic surgery, wound healing, tissue engineering and neurological/central nervous system and are used in hospitals and clinics, ambulatory surgical centers and other end users.

The biomaterials market research report is one of a series of new reports from The Business Research Company that provides biomaterials market statistics, including biomaterials industry global market size, regional shares, competitors with a biomaterials market share, detailed biomaterials market segments, market trends and opportunities, and any further data you may need to thrive in the biomaterials industry. This biomaterials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The biomaterials market size has grown rapidly in recent years. It will grow from $118. 51 billion in 2023 to $136. 08 billion in 2024 at a compound annual growth rate (CAGR) of 14. 8%. The growth in the historic period can be attributed to growing aging population, adoption of biomaterials in orthopedic and dental applications, increasing awareness of environmental sustainability, increased prevalence of chronic conditions medicine, increased demand for medical implants.

The biomaterials market size is expected to see rapid growth in the next few years. It will grow to $230 billion in 2028 at a compound annual growth rate (CAGR) of 14. 0%. The growth in the forecast period can be attributed to shifting consumer preferences, surge in demand for biomaterials in 3d printing and additive manufacturing, expansion of the biodegradable and bioresorbable biomaterials segment, adoption of biomaterials in drug delivery systems for personalized medicine, increasing use of biomaterials in wound care and tissue regeneration. Major trends in the forecast period include development of smart biomaterials with responsive and adaptive properties, integration of nanotechnology for enhanced functionality, emphasis on precision medicine leading to customized biomaterial solutions, exploration of marine and plant-derived biomaterial sources, collaboration between biomaterial companies and healthcare institutions for innovative applications.

The rising incidence of cardiovascular diseases is driving the growth of the biomaterials market. Cardiovascular disorders are caused by high blood pressure, smoking, high cholesterol, inactivity, and other factors. The increase in the prevalence of cardiovascular disorders is mainly due to noncontagious diseases such as diabetes, chronic respiratory illness, coronary artery disease (CAD) and heart attacks due to hypertension. Biomaterials such as heart valves, cardiopulmonary bypass systems, stents, vascular grafts, complete artificial hearts, and pacemakers are used as a healing mechanism for damaged and diseased heart tissue. For instance, in May 2023, according to the Centers for Disease Control and Prevention, a US-based public agency, coronary artery disease (CAD) was responsible for killing 375,476 people in 2021, and about 1 in 20 adults age 20 and older had CAD. In addition, about 2 in 10 deaths from CAD happen to adults less than 65 years old. Therefore, the rising incidence of cardiovascular diseases will increase the demand for biomaterials market.

The increasing healthcare spending will propel the growth of the biomaterials market. Healthcare spending refers to the total financial resources allocated for medical services, treatments, and healthcare infrastructure within a given period, typically on a national or institutional level. Healthcare spending is used in biomaterials for research and development, product development, procurement and adoption, and regulatory compliance. For instance, in September 2022, according to MedTech Europe, a Belgium-based European trade association representing the medical technology industries, in Europe, on average, approximately 11% of gross domestic product (GDP) is allocated to healthcare. Out of this, about 7. 6% is attributed to medical technologies. The spending on medical technology across European countries ranges from around 5% to 12% of the total healthcare expenditure. The per capita expenditure on medical technology in Europe stands at approximately $346. 08 (€284). Therefore, increasing healthcare spending will contribute to the growth of the biomaterials market.

Strategic partnerships are a key trend gaining popularity in the biomaterials market. Key companies are focusing on partnerships to develop new implants and combination devices based on biomaterials by leveraging each other's expertise, technology, and resources. These partnerships are also focused on enhancing the adoption of biomaterials. Such partnerships enable companies to gain a competitive edge in the market and increase revenue. For instance, in September 2021, Cambium Biomaterials, a US-based producer of ultra-high-performance biomaterials, partnered with Ginkgo Bioworks Inc., a US-based biological engineering company, to accelerate industrial adoption of high-performance biomaterials. The collaboration will use Ginkgo's Codebase and high-throughput facilities to speed Cambium's discovery, development, manufacture, and commercialization of biomaterials that provide superior performance and sustainability across a variety of industries.

Major companies operating in the biomaterials market focus on technological advancements, such as the designed enzymatic biomaterials (DEB) technology platform, to deliver sustainable biopolymers and gain a competitive advantage. The enzymatic biomaterials (DEB) technology platform involves the use of enzymes to design and modify materials for various applications, including drug delivery, tissue engineering, and diagnostics. For instance, in June 2023, International Flavors & Fragrances Inc., a US-based producer of flavors, fragrances, and cosmetic actives, launched the enzymatic biomaterials technology platform for the development of biobased materials at scale. Designed to deliver meaningful sustainability benefits with performance comparable to or superior to fossil-based materials, DEB technology helps to address growing preferences for environmentally friendly, high-performance biopolymers. The technology platform allows producers to fulfill regulatory changes and increasing consumer demand by replacing traditional fossil-based synthetic polymers.

In January 2021, Evonik Industries AG, a German specialty chemicals company acquired the LACTEL business of biodegradable polymers from DURECT Corporation for $15 million. With this acquisition, Evonik aims to expand in fast-growing markets such as biomaterials for tissue engineering, advanced drug delivery, and the 3D printing of implantable medical devices. DURECT Corporation is a US-based specialty pharmaceutical company.

Major companies operating in the in the biomaterials market report are Carpenter Technology Corporation, Corbion N V, Evonik Industries AG, Heraeus Medical Components LLC, Berkeley Advanced Biomaterials Inc., Zimmer Biomet Holdings Inc., DSM Biomedical BV, PolyNovo Limited, Baxter International Inc., Stryker Corporation, Collagen Solutions plc, Invibio Ltd., Aap Implantate AG, Cam Bioceramics BV, CeramTec GmbH, CoorsTek Medical LLC, CryoLife Inc., Cerapedics Inc., Surmodics Inc., Secant Group LLC, GELITA AG, Quattroflow GmbH, Kyocera Corporation, Wright Medical Group NV, KLS Martin Group GmbH & Co KG, Meccellis Biotechnology Co Ltd., Bio-on SpA, Coloplast A/S, Collagen Matrix Inc., IntrinsiQ Materials Inc., PolyActiva Pty Ltd

North America was the largest region in the biomaterials market in 2023. The regions covered in the biomaterials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the biomaterials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

The biomaterials market consists of sales of metals, polymers, and composites. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified)).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Biomaterials Market Characteristics

3. Biomaterials Market Trends And Strategies

4. Biomaterials Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Biomaterials Market Size and Growth

  • 5.1. Global Biomaterials Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Biomaterials Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Biomaterials Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Biomaterials Market Segmentation

  • 6.1. Global Biomaterials Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Metallic Biomaterial
  • Polymeric Biomaterials
  • Natural Biomaterials
  • Ceramics
  • 6.2. Global Biomaterials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Cardiovascular
  • Orthopedic
  • Ophthalmology
  • Dental
  • Plastic Surgery
  • Wound Healing
  • Tissue Engineering
  • Neurological/Central Nervous System
  • 6.3. Global Biomaterials Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals And Clinics
  • Ambulatory Surgical Centers
  • Other End Users

7. Biomaterials Market Regional And Country Analysis

  • 7.1. Global Biomaterials Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Biomaterials Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Biomaterials Market

  • 8.1. Asia-Pacific Biomaterials Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Biomaterials Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Biomaterials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8. 4. Asia-Pacific Biomaterials Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Biomaterials Market

  • 9.1. China Biomaterials Market Overview
  • 9.2. China Biomaterials Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Biomaterials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9. 4. China Biomaterials Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Biomaterials Market

  • 10.1. India Biomaterials Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Biomaterials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Biomaterials Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Biomaterials Market

  • 11.1. Japan Biomaterials Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.2. Japan Biomaterials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Biomaterials Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Biomaterials Market

  • 12.1. Australia Biomaterials Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Biomaterials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Biomaterials Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Biomaterials Market

  • 13.1. Indonesia Biomaterials Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Biomaterials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Biomaterials Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Biomaterials Market

  • 14.1. South Korea Biomaterials Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.2. South Korea Biomaterials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Biomaterials Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Biomaterials Market

  • 15.1. Western Europe Biomaterials Market Overview
  • 15.2. Western Europe Biomaterials Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Biomaterials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15. 4. Western Europe Biomaterials Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Biomaterials Market

  • 16.1. UK Biomaterials Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Biomaterials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Biomaterials Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Biomaterials Market

  • 17.1. Germany Biomaterials Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Biomaterials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Biomaterials Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Biomaterials Market

  • 18. 5. France Biomaterials Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18. 6. France Biomaterials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18. 7. France Biomaterials Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Biomaterials Market

  • 19. 9. Italy Biomaterials Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.10. Italy Biomaterials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.11. Italy Biomaterials Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Biomaterials Market

  • 20.13. Spain Biomaterials Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.14. Spain Biomaterials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.15. Spain Biomaterials Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Biomaterials Market

  • 21.1. Eastern Europe Biomaterials Market Overview
  • 21.2. Eastern Europe Biomaterials Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Biomaterials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21. 4. Eastern Europe Biomaterials Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Biomaterials Market

  • 22.1. Russia Biomaterials Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Biomaterials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Biomaterials Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Biomaterials Market

  • 23.1. North America Biomaterials Market Overview
  • 23.2. North America Biomaterials Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Biomaterials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23. 4. North America Biomaterials Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Biomaterials Market

  • 24.1. USA Biomaterials Market Overview
  • 24.2. USA Biomaterials Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Biomaterials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24. 4. USA Biomaterials Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Biomaterials Market

  • 25.1. Canada Biomaterials Market Overview
  • 25.2. Canada Biomaterials Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Biomaterials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25. 4. Canada Biomaterials Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Biomaterials Market

  • 26.1. South America Biomaterials Market Overview
  • 26.2. South America Biomaterials Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Biomaterials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26. 4. South America Biomaterials Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Biomaterials Market

  • 27.1. Brazil Biomaterials Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Biomaterials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Biomaterials Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Biomaterials Market

  • 28.1. Middle East Biomaterials Market Overview
  • 28.2. Middle East Biomaterials Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Biomaterials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28. 4. Middle East Biomaterials Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Biomaterials Market

  • 29.1. Africa Biomaterials Market Overview
  • 29.2. Africa Biomaterials Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Biomaterials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29. 4. Africa Biomaterials Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Biomaterials Market Competitive Landscape And Company Profiles

  • 30.1. Biomaterials Market Competitive Landscape
  • 30.2. Biomaterials Market Company Profiles
    • 30.2.1. Carpenter Technology Corporation
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1. 4. Financial Performance
    • 30.2.2. Corbion N V
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2. 4. Financial Performance
    • 30.2.3. Evonik Industries AG
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3. 4. Financial Performance
    • 30.2. 4. Heraeus Medical Components LLC
      • 30.2. 4.1. Overview
      • 30.2. 4.2. Products and Services
      • 30.2. 4.3. Strategy
      • 30.2. 4. 4. Financial Performance
    • 30.2. 5. Berkeley Advanced Biomaterials Inc.
      • 30.2. 5.1. Overview
      • 30.2. 5.2. Products and Services
      • 30.2. 5.3. Strategy
      • 30.2. 5. 4. Financial Performance

31. Global Biomaterials Market Competitive Benchmarking

32. Global Biomaterials Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Biomaterials Market

34. Biomaterials Market Future Outlook and Potential Analysis

  • 34.1 Biomaterials Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Biomaterials Market In 2028 - Segments Offering Most New Opportunities
  • 34. 3 Biomaterials Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35. 4. Research Inquiries
  • 35. 5. The Business Research Company
  • 35. 6. Copyright And Disclaimer